Coronary heart disease in primary care: accuracy of medical history and physical findings in patients with chest pain - a study protocol for a systematic review with individual patient data. by Haasenritter, J. et al.
Haasenritter et al. BMC Family Practice 2012, 13:81
http://www.biomedcentral.com/1471-2296/13/81STUDY PROTOCOL Open AccessCoronary heart disease in primary care: accuracy
of medical history and physical findings in
patients with chest pain – a study protocol for a
systematic review with individual patient data
Jörg Haasenritter1*, Marc Aerts2, Stefan Bösner1, Frank Buntinx3,6, Bernard Burnand4, Lilli Herzig5,
J André Knottnerus6, Girma Minalu2, Staffan Nilsson7, Walter Renier3, Carol Sox8, Harold Sox8 and
Norbert Donner-Banzhoff1Abstract
Background: Chest pain is a common complaint in primary care, with coronary heart disease (CHD) being the
most concerning of many potential causes. Systematic reviews on the sensitivity and specificity of symptoms and
signs summarize the evidence about which of them are most useful in making a diagnosis. Previous meta-analyses
are dominated by studies of patients referred to specialists. Moreover, as the analysis is typically based on
study-level data, the statistical analyses in these reviews are limited while meta-analyses based on individual patient
data can provide additional information. Our patient-level meta-analysis has three unique aims. First, we strive to
determine the diagnostic accuracy of symptoms and signs for myocardial ischemia in primary care. Second, we
investigate associations between study- or patient-level characteristics and measures of diagnostic accuracy. Third,
we aim to validate existing clinical prediction rules for diagnosing myocardial ischemia in primary care. This article
describes the methods of our study and six prospective studies of primary care patients with chest pain. Later
articles will describe the main results.
Methods/Design: We will conduct a systematic review and IPD meta-analysis of studies evaluating the diagnostic
accuracy of symptoms and signs for diagnosing coronary heart disease in primary care. We will perform bivariate
analyses to determine the sensitivity, specificity and likelihood ratios of individual symptoms and signs and
multivariate analyses to explore the diagnostic value of an optimal combination of all symptoms and signs based
on all data of all studies. We will validate existing clinical prediction rules from each of the included studies by
calculating measures of diagnostic accuracy separately by study.
Discussion: Our study will face several methodological challenges. First, the number of studies will be limited.
Second, the investigators of original studies defined some outcomes and predictors differently. Third, the studies
did not collect the same standard clinical data set. Fourth, missing data, varying from partly missing to fully missing,
will have to be dealt with.
Despite these limitations, we aim to summarize the available evidence regarding the diagnostic accuracy of
symptoms and signs for diagnosing CHD in patients presenting with chest pain in primary care.
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Chest pain is a frequent complaint in many health care
settings. In primary care 0.7% to 2.7% of patient encoun-
ters are due to chest pain [1-3]. However, the prevalence
of serious cardiac disease in these patients, e.g., chronic
stable coronary heart disease (CHD) or acute coronary
syndrome (ACS), is low. In unselected patients present-
ing with chest pain in primary care, the overall preva-
lence of coronary heart disease is between 12.8 and
14.6% [2,3]. In the majority of patients, the underlying
etiology is musculoskeletal, esophageal, respiratory, psy-
chological, or is unknown.
Primary care physicians (PCP) face several challenges
in diagnosing CHD. In primary care, patients with CHD
often present in the early stages of their disease, often
with uncharacteristic clinical findings that make the sep-
aration from other etiologies difficult. PCPs must reliably
identify serious cardiac disease while also protecting
patients from unnecessary testing and hospital admis-
sions. They must rely on the history, physical findings,
and their accumulated knowledge of an individual pa-
tient to determine the clinical probability of CHD and
decide whether testing, specialist referral or hospital ad-
mission is indicated. Tests ( i.e. troponin levels, and the
electrocardiogram) lack sensitivity in the early stages of
myocardial infarction (MI) and cannot exclude acute is-
chemia in patients with a high clinical probability. Lastly,
the optimal early evaluation of possible CHD uses the
patient’s clinical probability in order to decide on the
value of further testing and to interpret test results using
probabilistic reasoning, a form of thinking that many
physicians do not use [4].
The accuracy of medical history and physical examin-
ation for CHD has been the subject of previous meta-ana-
lyses. Mant et al.. studied the diagnostic value of
symptoms and signs for ACS and myocardial infarction
(MI) in studies published until 1999 [5]. Bruyninckx et al.
focused on the value of 10 pre-specified clinical symptoms
and signs in diagnosing ACS and MI [6]. Chun and
McGee did not restrict their research question to pre-
specified symptoms. Target diseases were stable CHD,
ACS, and MI [7]. Their search was conducted in 2003.
The studies included in these reviews have important
limitations, especially for application to the primary care
setting. Nearly all were conducted in emergency depart-
ments of hospitals, or secondary and tertiary care. The
respective settings differ with regard to the prevalence
and clinical presentation of CHD or other serious condi-
tions. Sox and colleagues showed that varying prevalence
of CHD in primary and secondary care resulted in diver-
ging predictive values of a clinical prediction rule [8].
Additionally, several authors have supposed that sensi-
tivity and specificity of medical tests also vary across
different settings [9-11]. Thus, results of diagnosticaccuracy studies conducted in other settings should not
be assumed to apply to office-based primary care.
Furthermore, the authors of these reviews synthesized
the results using aggregate data from each study, such as
the 2 by 2 tables of diagnostic accuracy. In contrast,
meta-analyses using individual patient data (IPD) con-
sider the whole information about each patient that is
available in the primary studies. This increases the scope
of possible statistical analyses. For example, IPD meta-
analysis allows investigation of the relationship between
patient-level characteristics like sex and age and the
diagnostic accuracy of a test [12,13]. Single symptoms
and signs are rarely sufficient to reliably diagnose CHD.
This problem may be overcome by developing a predic-
tion rule that combines several symptoms, signs, and
other patient characteristics like sex, age and coronary
risk factors. A meta-analysis using individual patient
data allows the construction of such a prediction rule as
well as the validation of existing clinical prediction rules.
Objectives of the study
In order to provide PCPs with evidence that applies to
their clinical setting, we will perform a systematic review
and meta-analysis using individual patient data. We will
include only studies conducted in office-based primary
care. The aims of this review are:
 to determine the diagnostic accuracy of symptoms
and signs for myocardial ischemia in primary care
patients
 to explore possible associations between study- or
patient-level characteristics and measures of
diagnostic accuracy.
 to validate existing prediction rules for diagnosing
myocardial ischemia in primary care.
The aim of this preliminary report is to describe the
methods of our study and the study populations that
comprise the meta-analysis.
Methods/Design
Study inclusion criteria
The studies to be included must fulfill the following
criteria:
Patients
We will include studies recruiting unselected adult
patients presenting with chest pain in office-based pri-
mary care practice. Studies are not eligible if the patients
have been recruited in emergency departments of hospi-
tals, by paramedics, or if the patients have been pre-
selected by PCPs or other health professionals based on
the likelihood of an underlying CHD. If patients of all
Table 1 Search terms (PubMed)
Searching for chest pain in title/abstracts chest[TIAB] pain[TIAB]
OR OR
thoracic[TIAB] pains[TIAB]
OR OR
thorax[TIAB] discomfort[TIAB]
AND OR
complaint*[TIAB]
OR
distress*[TIAB]
OR
pressure*[TIAB]
OR
numbness[TIAB]
OR
Searching for chest pain in MeSH Terms "chest pain"[MeSH]
AND
Searching for Primary Care in title/ abstract "general practitioner”[TIAB]
“general practitioners”[TIAB]
“general practice”[TIAB] OR
“family practice”[TIAB]
“family practitioners[TIAB]
“family practitioner”[TIAB]
“family medicine”[TIAB]
“family physician”[TIAB]
“family physicians”[TIAB]
“family doctor”[TIAB]
“family doctors”[TIAB]
“primary care”[TIAB]
OR
Journales relevant for Primary Care "BMC Fam Pract"[TA]
"Fam Pract"[TA]
"J Fam Pract"[TA]
"Fam Pract Res J"[TA]
"J Am Board Fam Pract"[TA]
"Br j gen pract"[TA]
“J R Coll Gen Pract” [TA]
“J Coll Gen Pract” [TA]
“J Coll Gen Pract Res Newsl”[TA] OR
"Can fam physician"[TA]
"Ann Fam Med"[TA]
"Aust fam physician"[TA]
"Scand J Prim Health Care"[TA]
"Eur J Gen Pract"[TA]
“J Gen Intern Med”[TA]
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Table 1 Search terms (PubMed) (Continued)
"Arch Fam Med"[TA]
"Aten Primaria"[TA]
OR
Searching for Primary Care in the affiliation of the author “general practice” [AD]
“family practice*” [AD]
“family medicine”[AD] OR
“primary care” [AD]
community [AD]
Searching for Primary care in MeSH "Family Practice"[MeSh]
"Physicians, Family"[MeSh] OR
"Primary Health Care"[MeSh]
Limits: NOT: Editorial, Addresses, Bibliography, Biography, Case Reports, Comment, Dictionary, Directory, Festschrift, Government Publications, Guideline, Historical
Article, In Vitro, Interactive Tutorial, Interview, Legal Cases, Legislation, Patient Education Handout, Portraits, Webcasts.
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clude patients aged < 18 years in the analysis.
Index tests
The diagnostic tests under evaluation will include items
of history and physical examination like symptoms,
signs, age, sex, coronary risk factors. We will not exclude
studies or discard individual items because the studies
defined the items differently or used different wording of
the questions in the standard data set.
Target disease/ reference standard
CHD is the reference condition. We will not exclude stud-
ies because of differing case definitions (e.g. ACS vs. stable
CHD). Coronary angiography is supposed to be the defin-
ite reference standard in diagnosing CHD. However, since
the likelihood of CHD in most patients presenting in pri-
mary care is low, this reference test is too invasive. Knott-
nerus and colleagues suggest that follow up of the clinical
course during an appropriate period is a good alternative.
They refer to this design as delayed-type cross-sectional
design [14]. However, we will not exclude studies because
of differing method for establishing the reference diagnosis
(e.g. independent reference panel; diagnosis by the GP that
cared for the patient).
Data collection
We will exclude studies in which the clinical findings
were obtained retrospectively from medical records.
Study identification and study selection
We will perform a computerized search in MEDLINE
(National Library of Medicine), and EMBASE (Excerpta
Medica). Terms identifying chest pain will be used along
with terms to identify studies conducted in primary care.
Search strategies will include subject headings (MeSH,Embtree) as well as free-text terms (Table 1). Further-
more, will perform a hand search in the online published
abstracts of the annual meetings of the North American
Primary Care Research Group and the European General
Practice Research Network. Additionally, we will check
the reference lists of all relevant articles. We will ask
authors of relevant articles if they are aware of studies
which are unpublished, ongoing, or which we have not
identified until now. We invite readers who know of
such studies to contact us.
Study quality assessment
At study level we will extract information on methodo-
logical characteristics of the studies, such as inclusion
criteria, patient recruitment, data collection, and refer-
ence standard from publications. Data not retrievable
from published reports will be requested from original
investigators. Two reviewers, who have not been
involved in the conduct of any of the primary studies,
will independently assess the internal validity and meth-
odological quality of each study using the quality assess-
ment tool for diagnostic accuracy studies (QUADAS)
[15,16]. They will resolve disagreements by discussing
their findings.
Outcome and index tests
Each study in our final data set will contain data on pa-
tient identifier code, patient’s age and gender, PCP iden-
tifier code, data on absence or presence of at least one
symptom or sign, and results on the final diagnosis. The
diagnostic outcome variable will be any manifestation of
CHD. As index tests we will consider each item of the
medical history or clinical examination. However, we
cannot expect that all studies gathered data on the same
symptoms and signs or that they used the same wording,
definition, operationalization, or coding of the data.
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had been written in different languages, we will translate
the variables used in the individual studies into English
and will create a synopsis showing the names, definitions
and categories of all variables. Using this synopsis we
will identify any symptom and sign that was collected in
at least two studies and that should therefore be
included in the analysis. Based on the studies we have
identified so far following variables will be included in
the analysis:
Age
Sex
Context of consultation
Did the patient require a home visit?
Did the PCP know the patient?
Was the encounter an emergency/ an urgent visit?
Was chest pain the main complaint?
Was CP present during consultation?
Had the patient experienced CP before?
PCPs’/ Patients’ concern
Did the GP assumed something serious?
Probability of CHD rated by PCP
Was the patient anxious?
Did the patient think the pain is related to the heart?
Pain characteristics - localization
Retrosternal CP
Precordial CP
Left-sided CP
Right-sided CP
Pain characteristics – radiation
Band-shaped radiation of pain
CP radiating to left shoulder/arm
CP radiating to right shoulder/arm
CP radiating to neck, jaw, bottom side of face
CP radiating to abdomen
Pain characteristics intensity
Intensity of CP
Pain characteristics – quality/ word descriptors
Stabbing pain
Oppressive pain
Burning pain
Dull pain
Pain characteristics – duration and course
Time since first occurrence of the pain
Continuous pain
Duration of a typical pain episode
Frequency of CP
Clinical Course of pain
Pain characteristics - classification
Typical angina
Unspecific CP
Pain depend on/ provoked by / related to
CP related to breathingCP related to movement
CP related to swallow
CP related to ingestion
CP related to effort/ exercise
CP related to cough
CP related to body position
Relief after administration of NTG
Relief after administration of antacid
Additional complaints/associated symptoms
Fever
Cough
Dyspnea
Sweating
Paleness
Nausea
Signs of a cold/ respiratory infect
Sputum
Reduced state of consciousness
Physical examination
Heart rate
Blood pressure
Arrhythmia
Pulmonary auscultation
Cardiac auscultation
Pain reproducible by palpation
Medical history – coronary risk factors, previous cardiac
events
History of dyslipidemia/ hyperlipidemia
History of diabetes (diabetes mellitus)
Family history of myocardial infarction
History of hypertension
Smoking
History of myocardial infarction
History of known CHD
Number of cardiovascular risk factors
(PCP primary care physician, CP chest pain, CHD
coronary heart disease)
Data management
Using the synopsis of the variables we will recode the
original data sets. We will then check the recoded data
sets whether values seem to be plausible, realistic, con-
sistent, and at least similar to the results published by
the researchers. Additionally, the individual investigators
of the each of the original studies will validate the results
of the translation and recoding process.
Cases aged< 18 years and cases with missing values in
the diagnostic outcome variable will be excluded. If results
on individual index tests are available on study level but
are missing on individual patient level we will consider
this as missing at random and impute the missing values.
According to the well-established approach of multiple
imputation we will create five imputed data sets for each
original study [17,18] and merge them into five imputed
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tial source of between-study heterogeneity. If substantial
between-studies heterogeneity will occur in the analyses of
single symptoms and signs, translation and matching of
the respective variables will have to be discussed by the
study team.
Data analysis
Primary objectives of the statistical analyses are to inves-
tigate the diagnostic accuracy of symptoms and signs
and to explore possible associations between study- or
patient-level characteristics and measures of diagnostic
accuracy. In order to achieve these aims we will use dif-
ferent approaches.
In the bivariate analysis we will investigate the diag-
nostic accuracy of single symptoms and signs. In a first
study-specific step we will calculate values of sensitivity,
specificity and likelihood ratios for the single index tests
within the individual studies. All statistical models in
this step will be formulated as logistic regression models,
with test status as response, and the disease status as ex-
planatory variable [19]. To deal with sparsity (small
number of cases in certain combinations of CHD status
and symptoms and signs), we will apply Firth’s method
to correct for small sample bias [20]. We will combine
the results of the imputed data sets within the individual
studies using recommended techniques of multiple im-
putation [17,18]. We will plot the results for each clinical
feature in forest plots. It is possible to extend the model
to evaluate the impact of age and gender within the indi-
vidual studies. However, the ultimate goal of this ap-
proach is to pool the results for a single symptom and
sign across studies while accounting for individual pa-
tient (age and gender) and study characteristics. The
feasibility of the bivariate random effects meta-analysis
framework that Riley and colleagues recommended for
this task largely depends on the number of studies [12].
Since the studies do not provide data on the all index
tests, the number of studies considered in the individual
analyses will vary between 2 and n, where n is the num-
ber of all included studies.
In the multivariate approach we will determine opti-
mal combinations of symptoms and signs. Similar to the
bivariate analysis we will use a stepwise approach. In a
first step, the study-specific multivariate analysis, we will
determine optimal combinations of symptoms and signs
within the individual studies. In order to achieve that
aim we will use a random forest algorithm to identify
the most important index tests in each study. The ran-
dom forest algorithm is a powerful data-driven method
for identifying important variables [21]. Next, we will fit
a logistic regression model with all index tests selected
in this way and their two way interaction terms. We will
perform these steps separately for each imputed data setof each original study. All index tests which will be sig-
nificant (α= 5%) in at least one of the study-specific
imputed data sets will be included in a candidate list.
We will combine the results of the imputed data sets
within each individual study according to the inferential
methodology of multiple imputation [17,18]. As a result
of this step we will identify study-specific models which
only include symptoms and signs that are independently
associated with the presence of CHD. These study-
specific analyses will provide important explorative
insights in the heterogeneity between different studies.
We expect differences in study design, slightly varying
definitions of variables and varying population character-
istics to play a role here. Results will guide the model
building process for the next step, the multivariate
meta-analysis. In this approach we will merge the study-
specific imputed data sets to five imputed meta data
sets. We will enter all index tests included in the candi-
date list into the model and fit the logistic regression
model (1) to each imputed meta data set:
Logit P Yij ¼ 1
   ¼ β0 i þ
XP
k¼1
βkXkijIki ;
i ¼ 1; 2; . . . ; n; j ¼ 1; 2; . . . ; ni ð1Þ
where Yij is the outcome variable for patient j in study i
(0 indicates that CHD is absent, while 1 indicates that
CHD is present), Xk represents the result of the kth
index test, β0i is the study-specific intercept for the ith
study, βk is the coefficient for the index test Xk, Iki is the
study indicator for the kth index test (1 if the test result
is available in individual study i, or 0 if the test result is
not available in individual study i), P is the number of
index tests, ni is the number of patients in study i, and n
is the number of studies. Study-specific intercepts will
account for heterogeneity across studies and for the fact
that the individual studies will contribute data on differ-
ent sets of index tests. However, model (1) assumes that
the effect of a single index test is fixed across studies. A
random effects model is possible, but more complex and
might be not feasible if the number of studies is small.
The multivariate meta-analysis will result in a clinical
prediction rule with optimal diagnostic accuracy charac-
teristics. The unique linear combination of selected
symptoms and signs with their estimated regression
coefficients from the final model defines a “clinical chest
pain score”. If the score exceeds a threshold value, the
patient is labeled CHD positive; if the score is less than a
threshold value, the patient is labeled CHD negative.
Such a prediction rule is “personalized” on the one hand
and applicable to individuals in a broad community cov-
ering several countries or regions and thus exceeding
the validity of individual studies on the other hand.
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approach will be formulated as logistic regression mod-
els, with CHD as response, and the symptoms and signs
as explanatory variables. In order to describe the dis-
criminatory power of the study-specific models and the
meta model we will calculate the area under the receiver
characteristic curve (AUC). In addition, we will calculate
the values of sensitivity, specificity and likelihood ratios
for different thresholds of the clinical prediction rule.
Since the maximum likelihood (ML) estimates of a lo-
gistic regression model are not necessarily maximizing
the AUC, we will compare the ML results with the alter-
native approach of Pepe et al. [22]. In this approach the
estimates are directly maximizing the AUC. By definition
the “clinical chest pain score” based on the AUC-
maximizing estimates will have improved diagnostics ac-
curacy characteristics, but the improvement might be so
negligible that this more computationally demanding ap-
proach is not worthwhile. We will examine both
approaches, and the final choice will depend on the
magnitude and the practical relevance of the improve-
ment. Furthermore, we will apply internal validation
techniques in order to validate the “clinical chest pain
score” from the final model of the multivariate meta-
analysis.
A secondary objective of the statistical analysis is the
external validation of clinical prediction rules (CPR)
aimed to support PCPs in diagnosing myocardial ische-
mia in patients with chest pain. We are aware of several
rules developed or validated in a primary care setting
and based on items of the medical history and clinical
examination. [8,23-26]. These CPRs used different pre-
dictor variables and definitions of myocardial ischemia,
e.g. any CHD, or myocardial infarction. If a study pro-
vides data on the required predictors of one or more
CPR, we will calculate measures of overall discrimin-
ation (area under the curve) and diagnostic accuracy
(sensitivity, specificity, likelihood ratios) for recom-
mended thresholds within the individual data set. We
will present the results separately for each study and
CPR. If the number of studies providing data on one sin-
gle CPR is sufficient we will calculate pooled estimates
of sensitivity and specificity across studies using the ap-
proach recommended by Riley et al. [12].Studies identified to date
To date, we have identified six relevant studies, includ-
ing about 4000 patients and conducted in five different
countries [2,8,23,27-29]. All six studies investigated pro-
spectively the diagnostic accuracy of symptoms and
signs for CHD in consecutive series of patients with
chest pain in a primary care setting. The number of
patients in the studies ranged from 323 to 1249. Eachstudy used a delayed-type reference standard to establish
the reference diagnosis. The studies differ in the dur-
ation of follow-up and the person who made the refer-
ence diagnosis. Study characteristics are summarized in
Table 2.
The investigators of these six studies have agreed to
collaborate as the international working group on chest
pain in primary care (INTERCHEST) and to provide the
data from each study to perform a meta-analysis with in-
dividual patient data. An initial meeting took place in
January 2010. The coordinating center is the Depart-
ment of General Practice, University of Marburg, Ger-
many. In a series of video conferences, the whole group
has discussed major questions about organizing the data,
conducting the analysis, and interpreting the findings.
We are inviting investigators of future eligible studies to
join this collaboration.
Discussion
Systematic reviews on the accuracy of diagnostic tests
with subsequent meta-analysis of the measures of diag-
nostic accuracy can play an important role in decision
making. They allow more precise estimates of sensitivity
and specificity. However, the interpretation of the results
is not straightforward. A high degree of heterogeneity or
between-study variance that is not due to chance vari-
ation is a frequent finding in diagnostic accuracy
reviews. Investigating the different sources of this het-
erogeneity is important [30,31]. Heterogeneity can be
caused by study-level characteristics like methodological
differences in design or conduct of the study (bias),
between-study differences in defining test positives (dif-
ferent cut-points), or other design-related characteristics
[30,31]. Furthermore, patient-level characteristics can act
as modifiers of diagnostic accuracy [12]. For example,
data from secondary care suggests that the sensitivity
and specificity of the history and physical findings may
vary according to patient characteristics like age [32],
sex [33,34], or stage of the target condition. While in-
dividual studies often lack statistical power to reliably
estimate these effect modifications, aggregate data meta-
analysis cannot investigate patient-level modifiers of
diagnostic efficacy [12,13].
Most individual symptoms and signs are insufficiently
discriminative to diagnose CHD. This problem may be
overcome by combining several findings into a clinical
prediction rule. Several clinical prediction rules (CPR)
have been developed to support physicians in diagnos-
ing myocardial ischemia in patients with chest pains
[8,23-26]. We can test these rules in the pooled data set
of primary care patients with chest pain.
Several methodological problems make it difficult to
anticipate the results of our study. The individual studies
were conducted over a span of almost thirty years during
Table 2 Characteristics of studies identified to date
Characteristic Sox et al. [8] Buntinx et al.
[23]
Nilsson et al. [27] Verdon et al.
[2]
Bösner et al. [28] Haasenritter et al. [29]
Data collection 1982 1988 1998-2000 2001 2005-2006 2009-2010
Country USA Belgium Sweden Switzerland Germany Germany
Setting 66 PCPs
at 1 Drop-in clinic
25 PCPs 3 health care
centres each
served by 4 PCPs
58 PCPs
in private
practice
74 PCPs in
private
practice
56 PCPs in
private
practice
Number of
patients
404* 323 554 672 1249 880
Inclusion
criteria
Chest pain
as presenting
complaint, no
age limitation
(ages were 17
to 81 years;
average
41 years)
New episode
of chest pain,
discomfort or
tightness as
main or
ancillary
complaint
New episode
of chest pain,
discomfort or
tightness as
presenting
complaint;
aged 20–79
years; patients
were excluded:
if acute MI
or coronary
re-vascularization
during the
previous year
Chest pain
as main or
ancillary complaint;
age≥ 16
years
Chest pain
as main or
ancillary
complaint;
age≥ 35
years; excluded:
chest pain≥ 1
one month,
or had already
been investigated
Chest pain as
main or
ancillary complaint;
age≥ 35 years;
excluded: chest
pain≥ 1 one month,
or had already
been investigated
No age
limitation
(ages were 17
to 81 years;
average 41
years)
No age limitation
(ages were 1 to
88 years;
average 45 years)
Reference standard Delayed-type
reference
standard
Delayed-type
reference
standard
Delayed-type
reference
standard
Delayed-type
reference
standard
Delayed-type
reference
standard
Delayed-type
reference
standard
Duration of
follow-up
Average time
to diagnosis:
2 months (range –
to 8 months)
2 weeks
to 2 months
3 months 12 months 6 months 6 months
RD
established by
2 internist-
investigators
independently
assigned
diagnosis.
Treating
physicians
Treating
physicians
Treating
physicians
Independent
expert panel
(1GP, 1 cardiologist,
1 research fellow)
Independent
expert panel
(1GP, 1 research
fellow)
Prevalence of
CHD as cause
of chest pain
7.2% 9.6% 11.2% 12.6% 14.4% 10.6%
RD reference diagnosis, MI myocardial infarction, PCP primary care physician.
*The number of patients is greater than as previously reported [8] because it includes patients excluded in the published study (diagnosis was acute MI, first
episode of chest pain).
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largely because of troponin assays becoming available.
We expect semantic and cultural differences to com-
promise the comparability of study variables. Further,
given the results of previous systematic reviews [5-7],
the likelihood of finding eligible studies, in addition to
the ones previously mentioned, is small. Given a rela-
tively small pooled sample and the novelty of our statis-
tical methods, our statistical analyses should be regarded
as exploratory. As guideline developers build upon our
findings, they must remember these caveats and remindguideline users that medicine is an inexact art. However,
further research in this area requires large samples and
sophisticated methods for data collection and analysis.
The probability of further studies in this area is therefore
small.
We hope that the planned systematic review will ad-
vance our understanding in the following ways:
a) Clinical knowledge
We aim to report estimates of accuracy for single
signs and symptoms and for clusters of signs and
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in unselected patients presenting with chest pain in
primary care. In addition, we will investigate the
effect of patient characteristics like sex and age on
the diagnostic accuracy of signs and symptoms.
Furthermore, we will validate clinical prediction
rules for the diagnosis of CHD in primary care.
Based on these findings we will be able to give
recommendations regarding future research
including the investigation of diagnostic algorithms
based on combinations of findings of the history,
physical examination, and technological devices
(ECG, point of care blood tests for troponins or
other biomarkers).
b) Methodological knowledge
We will explore possible associations between study-
level and patient-level covariates on the one hand,
and sensitivity and specificity of medical tests on the
other hand. Based on the findings, we aim to
provide recommendations regarding the design of
future diagnostic studies in primary care and the
conduct of diagnostic accuracy reviews based on
individual patient data.
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